In the US, around US$20 billion worth of funds are invested in biotech ETFs, while mutual funds have poured another US$40 billion of investment into the sector. Photo: Andrew Brookes/Corbis

The best ways of climbing aboard the biotech investment bandwagon

Exchange traded or mutual funds allow those with no or limited knowledge of the biotech industry’s potential exposures to reduce risk

Topic |   Pharmaceuticals

TOP PICKS

In the US, around US$20 billion worth of funds are invested in biotech ETFs, while mutual funds have poured another US$40 billion of investment into the sector. Photo: Andrew Brookes/Corbis
READ FULL ARTICLE